Danoprevir Sodium Tablets was approved for marketing by the National Medical Products Administration (NMPA) in June 2018, and it is China’s first indigenously developed oral anti-hepatitis C virus (HCV) Class 1 innovative drug.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



